N/A
N=75
Prospective Trial Comparing Two Different Polypropylene Meshes for Inguinal Hernias
Hernia, Inguinal
Bottom Line
View on ClinicalTrials.gov: NCT01825187 ↗Enrolled (actual)
75
Serious AEs
0.0%
Results posted
Jun 2022
Primary outcome: Primary: Inguinal Hernia Mesh Insertion Times — 9.76; 8.70 Minutes — p=0.523
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ULTRAPRO Mesh (Device); 3DMAX (Device); Evaluation (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- South East Area Health Education Center, Wilmington, NC
- Primary completion
- Aug 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Inguinal Hernia Mesh Insertion Times |
9.76; 8.70 | 0.523 |
| SECONDARY NASA TLX Survey Index Scores |
7.63; 8.67; 6.67; 7.00; 7.46; 8.00 | 0.371 |
Summary
The purpose of this research study is to measure the clinical effectiveness of two different polypropylene meshes used for laparoscopic inguinal hernias by evaluating subjects' length of hospital stay, perioperative complications, recurrence rate, pain score, comfort level and postoperative quality of life. A secondary goal of the study is to evaluate the ease of use and time it takes surgical residents to place the mesh and perform the surgery using these two different meshes.
Eligibility Criteria
Inclusion Criteria
- Subjects undergoing laparoscopic repair for the treatment of either single or bilateral inguinal hernias
- All surgical residents at New Hanover Regional Medical Center
Exclusion Criteria
- Subjects requiring emergency surgery
- Pregnant subjects
- Subjects under the age of 18 years of age
Data sourced from ClinicalTrials.gov (NCT01825187). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.